Quality of life in heart failure: New data, new drugs and devices

Katarzyna Major; Aleksandra Bodys-Pełka; Marcin Grabowski; Małgorzata Lelonek

doi:10.5603/cj.92243

Quality of life in heart failure: New data, new drugs and devices

Cardiol J. 2024;31(1):156-167. doi: 10.5603/cj.92243. Epub 2023 Oct 12.

Authors

Katarzyna Major¹, Aleksandra Bodys-Pełka^{2

3}, Marcin Grabowski², Małgorzata Lelonek⁴

Affiliations

¹ Department of Noninvasive Cardiology, Medical University of Lodz, Poland. katarzyna.major@umed.lodz.pl.
² 1st Department of Cardiology, Medical University of Warsaw, Poland.
³ Doctoral School, Medical University of Warsaw, Poland.
⁴ Department of Noninvasive Cardiology, Medical University of Lodz, Poland.

Abstract

Quality of life (QoL) is a therapeutic goal in heart failure. There are many EBM therapies for improving QoL. In this study, data is presented on new pharmacotherapies and devices that impact QoL in the heart failure population.

Keywords: devices; heart failure; pharmacotherapy; quality of life.

MeSH terms

Heart Failure* / diagnosis
Heart Failure* / drug therapy
Humans
Quality of Life*